Vergoeding 2014-2018 voor ATC-subgroep N03AX : Overige anti-epileptica

  • Raming voor de totale Zvw-populatie
  2014 2015 2016 2017 2018
N03AX03 Sultiam (Ospolot ®) 2 1 155 . .
N03AX09 Lamotrigine (Lamictal ®) 2.633.400 2.572.100 2.558.800 2.435.500 2.689.900
N03AX10 Felbamaat (Taloxa ®) 135.090 134.530 128.000 132.360 119.180
N03AX11 Topiramaat (Topamax ®) 1.082.800 998.200 972.620 905.130 1.104.100
N03AX12 Gabapentine (Neurontin ®) 1.577.600 1.514.300 1.478.300 1.388.500 1.595.800
N03AX14 Levetiracetam (Keppra ®) 6.355.200 6.031.800 5.756.100 4.737.100 5.200.200
N03AX15 Zonisamide (Zonegran ®) 431.170 491.640 506.320 439.040 382.560
N03AX16 Pregabaline (Lyrica ®) 41.046.200 43.696.200 31.931.100 23.810.200 9.387.300
N03AX17 Stiripentol (Diacomit ®) 420.680 417.710 397.340 450.630 410.750
N03AX18 Lacosamide (Vimpat ®) 2.148.700 2.533.400 3.006.700 3.569.500 4.182.200
N03AX21 Retigabine 34.403 24.750 21.523 1.488 .
N03AX22 Perampanel (Fycompa ®) 75.220 386.940 527.780 548.030 594.420
N03AX23 Brivaracetam (Briviact ®) . . 48.261 436.970 950.320
Totaal 55.940.465 58.801.571 47.332.999 38.854.448 26.616.730